Federal Data HubHRSA 340B · JSON

Michael Reese Research and Education Foundation

HIV Care Program · 340B ID RWI60616

ParticipatingRWI

Michael Reese Research and Education Foundation is a RWI enrolled in the federal 340B Drug Pricing Program in Chicago, IL. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 13 contract-pharmacy arrangement(s) (12 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (13)

PharmacyLocationBeginTerminatedPharmacy ID
APOTHECARE, INC.CHICAGO, IL2011-10-012967
BOND DRUG COMPANY OF ILLINOIS, L.L.C.CHICAGO, IL2013-10-013396
BOND DRUG COMPANY OF ILLINOIS, L.L.C.CHICAGO, IL2026-07-017888
BOND DRUG COMPANY OF ILLINOIS, L.L.C.CHICAGO, IL2023-04-011641
WALGREEN CO.CHICAGO, IL2024-04-01108800
WALGREEN CO.CHICAGO, IL2026-07-013365
WALGREEN CO.CHICAGO, IL2026-07-017630
WALGREEN CO.CHICAGO, IL2026-07-013368
WALGREEN CO.CHICAGO, IL2026-07-0187379
WALGREEN CO.CHICAGO, IL2023-04-014984
WALGREEN CO.CHICAGO, IL2020-07-012026-05-20107300
WALGREEN CO.GLENVIEW, IL2024-04-018074
Walgreen COBolingbrook, IL2025-07-01136147

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.